NAFDAC introduces Small Business Support Desk
As part of its efforts to promote productive interaction with stakeholders and in line with President Goodluck Jonathan’s transformation agenda, the National Agency for Food and Drug Administration and Control (NAFDAC) has introduced ‘Small Business Support Desk’ to encourage small scale businessmen/women in various parts of the country. Director-General of NAFDAC, Dr. Paul Orhii, who […]
ALERT ON CODEINE CONTAINING COUGH SYRUP
Codeine is an opiate used for its analgesic (pain reliever) and more commonly antitussive effect (cough suppressant) in cough syrups. Codeine containing cough syrups are effective in the management of certain cough. However, it has a high potential for abuse and may present some serious adverse reactions to the user. For these reasons, access to […]
PUBLIC ALERT ON ROSIGLITAZONE (AVANDIA, AVANDAMET)
Rosiglitazone belongs to a class of antidiabetic drugs used to treat Type II diabetes. Worrying concerns on this drug were raised when it’s use in exposed patients was associated with increased cardiovascular adverse effects. The European Medicines Agency (EMA) had recommended the withdrawal of the drug from the European market after it concluded that the […]
